BioMaps

BioMap is a leading AI-powered life science company founded in 2020 by Baidu CEO Robin Li and Wei Liu. The company leverages its proprietary xTrimo foundation model, a trillion-parameter scale protein-centric large language model, to accelerate the discovery and design of novel biotherapeutics. BioMap operates a Model as a Service (MaaS) business model and has established high-value strategic partnerships, most notably a $1 billion+ collaboration with Sanofi to develop AI modules for drug discovery. Its platform integrates multi-omic data and high-throughput wet-lab validation to address complex biological challenges in immunology, oncology, and neurology.